Inventor · disambiguated record
Richard W. Gedrich
Also filed as: GEDRICH RICHARD · GEDRICH RICHARD W · GEDRICH RICHARD WALTER
4 granted patents·12 pending applications·38 citations·filing 2001–2023
74Inventor score
Files withBAYER HEALTHCARE LLC5ARVINAS OPERATIONS INC3BAYER SCHERING PHARMA AG2BAYER AG1BAYER AKTIENSEGELLSCHAFT1
Top patents by PatentIndex Score
16 records- 0189US6734006B2Regulation of human transmembrane serine proteaseBAYER AG·Filed 2001·Granted May 11, 2004·32 cites·23 claims
- 0281US8680124B2Treatment of cancers with acquired resistance to kit inhibitorsWILHELM SCOTT·Filed 2008·Granted Mar 25, 2014·5 cites·34 claims
- 0374US7622292B2Regulation of human transmembrane serine proteaseBAYER SCHERING PHARMA AG·Filed 2007·Granted Nov 24, 2009·1 cites·10 claims
- 0473US2010069615A1Regulation of Human Transmembrane Serine ProteaseBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 0567US2015018393A1Treatment of cancers with acquired resistance to kit inhibitorsBAYER HEALTHCARE LLC·Filed 2014·Application pending·0 cites
- 0667US2018311220A1Treatment of cancers with acquired resistance to kit inhibitorsBAYER HEALTHCARE LLC·Filed 2018·Application pending·0 cites
- 0766US2024066032A1Methods of treating prostate cancerARVINAS OPERATIONS INC·Filed 2023·Application pending·0 cites
- 0865US2024180900A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2023·Application pending·0 cites
- 0965US2010173954A1Treatment of cancers having resistance to chemotherapeutic agentsBAYER HEALTHCARE LLC·Filed 2008·Application pending·0 cites
- 1063US2017165242A1Treatment of cancers with acquired resistance to kit inhibitorsBAYER HEALTHCARE LLC·Filed 2017·Application pending·0 cites
- 1156US2022184078A1Methods of treating prostate cancerARVINAS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 1253US2017172989A1Treatment of cancers having resistance to chemotherapeutic agentsBAYER HEALTHCARE LLC·Filed 2017·Application pending·0 cites
- 1350US7314730B2Regulation of human transmembrane serine proteaseBAYER AKTIENSEGELLSCHAFT·Filed 2004·Granted Jan 1, 2008·0 cites·7 claims
- 1448US2022177593A1Anti-axl antibodies and methods of use thereofCELLDEX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1545US2011195110A1Urea compounds useful in the treatment of cancerSMITH ROGER·Filed 2006·Application pending·0 cites
- 1645US2006078498A1Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192BAYER PHARMACEUTICALS CORPORAT·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →